कृपया अन्य खोज का प्रयास करें
चिन्ह | एक्सचेंज | करेंसी | ||
---|---|---|---|---|
MDG1k | Xetra | EUR | देरी | |
MDG1d | BATS Europe | EUR | देरी | |
MDG1k | ट्रेडगेट | EUR | देरी | |
MDG1k | फ़्रंकफ़र्ट | EUR | देरी | |
MDG1k | विएना | EUR | रियल टाइम |
Medigene AG, a biotechnology company, focuses on the discovery and development of T-cell therapies for the treatment of cancer. The company’s end-to-end platform enables the development of T cell receptor engineered T cell (TCR-T) therapies for multiple tumor indications. Its pipeline includes MDG1015, a TCR-T therapy product to treat multiple solid tumor indications; MDG10xx to treat multiple solid tumor; and MDG1011, a TCR-T immunotherapy candidate, which is in clinical development to treat blood cancer. It also focuses on dendritic cell vaccines. Medigene AG has a strategic partnership with BioNTech to develop TCRbased immunotherapies against cancer; and 2seventy bio, Inc. for the development of TCR immunotherapies, as well as a collaboration agreement with National Cancer Institute to evaluate the potential of T cell receptors to be used in new cell constructs for the treatment of solid tumors. It has operations in Germany, the United States, and Asia. The company was founded in 1994 and is headquartered in Munich, Germany.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Frank Mathias | 59 | 2008 | Independent Member of the Supervisory Board |
Antoinette Hiebeler-Hasner | 63 | 2016 | Independent Deputy Chairwomen of the Supervisory Board |
Freda Stevenson | - | 2017 | Member of Scientific Advisory Board |
Anthony Man | 66 | 2020 | Independent Member of the Supervisory Board |
Micha Drukker | - | 2017 | Member of Scientific Advisory Board |
Peter H. Krammer | 56 | 2017 | Member of Scientific Advisory Board |
Jolanda de Vries | - | 2017 | Member of Scientific Advisory Board |
Lawrence E. Samelson | - | 2017 | Member of Scientific Advisory Board |
Ronald Scott | 67 | 2017 | Independent Member of the Supervisory Board |
Ernst-Ludwig Winnacker | 81 | 2016 | Co-Founder & Chairman Scientific Advisory Board |
Gerd Zettlmeissl | 68 | 2017 | Independent Chairman of the Supervisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है